Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Phase 2b Study of PTC124 in Duchenne/Becker Muscular Dystrophy (DMD/BMD)

This study has been completed.
Information provided by (Responsible Party):
PTC Therapeutics Identifier:
First received: January 1, 2008
Last updated: September 6, 2013
Last verified: September 2013
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2009
  Primary Completion Date: December 2009 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: July 11, 2011